Skip to main content
OpenTrials
Completed

NCT Number: NCT04471935

Speech Hero Home Therapy for Aphasia

The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants will be instructed to use Speech Hero for at least 10 hours over a 4-week period.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Broca Aphasia Aphasia Aphasia, Broca Communication Disorders Language Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Speech Disorders

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Callier Center at University of Texas Dallas

Richardson, Texas, 75080, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Broca's aphasia due to stroke,
  • >6 months post stroke
  • sufficient motor function of the unaffected upper extremity to tap on a table while speaking

Exclusion criteria

  • Incidence of other neurological diseases (though individuals with apraxia will be included)
  • age <85

Treatment and study plan

At home Speech Hero therapy app

Device

Participants will be instructed to use the Speech Hero therapy app for three hours per week over a 4-week period.

Primary outcomes

  1. Number of Participants That Used the Device for at Least Ten Hours Over the Course of Four Weeks

    Time frame: Immediately Post-Treatment, an average of 4 weeks

    Number of participants able to use the device on their own at home for at least 10 hours over four weeks without technical or other issues. Speech Hero will be deemed feasible for this population if at least 5 participants are able to use the device on their own at home for at least 10 hours over four weeks without technical or other issues.

Secondary outcomes

  1. Change in Score on Western Aphasia Battery

    Time frame: Immediately Post-Treatment, an average of 4 weeks

    Assessment of language function of adults with suspected neurological disorders as a result of a stroke, head injury, or dementia. The Western Aphasia Battery (WAB) is comprised of 8 subscales. For this study the subscales of spontaneous speech, auditory verbal comprehension, repetition, naming and word finding were used. Results reported as change in score from baseline to post-treatment (each subscale score is on 0-100% scale with higher score representing less impairment).

  2. Change in Score on Boston Naming Test

    Time frame: Immediately Post-Treatment, an average of 4 weeks

    Assessment of language function of adults with suspected neurological disorders as a result of a stroke, head injury, or dementia. Scoring counts the number of spontaneously produced correct responses, the number of cues given, and the number of responses after phonemic cueing and after semantic cueing. Results reported as change in score from baseline to post-treatment (score for Boston Naming Test (BNT) is on 0-100% scale with higher score representing less impairment).

Sponsors and collaborators

Lead sponsor

Flint Rehabilitation Devices, LLC

Industry

Collaborators

  • University of Texas

Registry information

Official study title

Speech Hero: a Rhythm-based Speech Therapy App for Individuals With Aphasia

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jul 15, 2020
Registry last updated
Feb 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.